-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明，无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
PetVivo (OTCMKTS:PETV) Shares Cross Above 50 Day Moving Average of $2.23
PetVivo (OTCMKTS:PETV) Shares Cross Above 50 Day Moving Average of $2.23
PetVivo Holdings, Inc. (OTCMKTS:PETV – Get Rating) crossed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $2.23 and traded as high as $2.59. PetVivo shares last traded at $2.41, with a volume of 18,760 shares changing hands.
PetVivo Price Performance
The stock has a fifty day moving average of $2.23 and a 200-day moving average of $2.00. The company has a quick ratio of 4.00, a current ratio of 4.15 and a debt-to-equity ratio of 0.01. The firm has a market capitalization of $24.27 million, a P/E ratio of -3.21 and a beta of 1.91.
Get PetVivo alerts:PetVivo (OTCMKTS:PETV – Get Rating) last released its quarterly earnings results on Thursday, August 11th. The company reported ($0.20) earnings per share (EPS) for the quarter. PetVivo had a negative net margin of 3,817.65% and a negative return on equity of 99.68%. The business had revenue of $0.06 million during the quarter.
Institutional Trading of PetVivo
A hedge fund recently bought a new stake in PetVivo stock. Truist Financial Corp bought a new position in shares of PetVivo Holdings, Inc. (OTCMKTS:PETV – Get Rating) in the 2nd quarter, according to its most recent 13F filing with the SEC. The fund bought 139,803 shares of the company's stock, valued at approximately $221,000. Truist Financial Corp owned 1.40% of PetVivo at the end of the most recent quarter. Institutional investors and hedge funds own 12.90% of the company's stock.About PetVivo
(Get Rating)
PetVivo Holdings, Inc, a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses.
Featured Articles
- Get a free copy of the StockNews.com research report on PetVivo (PETV)
- Is This Medical Gear Maker Ready To Continue Its Rally?
- The Five (5) Hottest Stocks To Watch Ahead Of Q3 Earnings
- Has Take-Two Interactive Devolved into a One-Trick Pony?
- Is Lyft Going To Make It As Acquisition Rumors Swirl?
- Four Cheap Stocks With Interesting Insider Activity
Receive News & Ratings for PetVivo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetVivo and related companies with MarketBeat.com's FREE daily email newsletter.
PetVivo Holdings, Inc. (OTCMKTS:PETV – Get Rating) crossed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $2.23 and traded as high as $2.59. PetVivo shares last traded at $2.41, with a volume of 18,760 shares changing hands.
PetVivo控股公司(OTCMKTS：PETV-GET评级)在周三的交易中突破了50日移动均线。该股的50日移动均线为2.23美元，交易价格高达2.59美元。PetVivo的股票最后报2.41美元，成交量为18,760股。
PetVivo Price Performance
PetVivo性价比
The stock has a fifty day moving average of $2.23 and a 200-day moving average of $2.00. The company has a quick ratio of 4.00, a current ratio of 4.15 and a debt-to-equity ratio of 0.01. The firm has a market capitalization of $24.27 million, a P/E ratio of -3.21 and a beta of 1.91.
该股的50日移动均线切入位为2.23美元，200日移动均线切入位为2.00美元。该公司的速动比率为4.00，流动比率为4.15，债务权益比率为0.01。该公司的市值为2427万美元，市盈率为-3.21，贝塔系数为1.91。
PetVivo (OTCMKTS:PETV – Get Rating) last released its quarterly earnings results on Thursday, August 11th. The company reported ($0.20) earnings per share (EPS) for the quarter. PetVivo had a negative net margin of 3,817.65% and a negative return on equity of 99.68%. The business had revenue of $0.06 million during the quarter.
PetVivo(OTCMKTS：PETV-GET Rating)上一次发布季度收益报告是在8月11日星期四。该公司公布了该季度每股收益(EPS)(0.20美元)。PetVivo的净利润率为负3817.65%，股本回报率为负99.68%。该业务在本季度的收入为60万美元。
Institutional Trading of PetVivo
PetVivo的机构交易
About PetVivo
关于PetVivo
(Get Rating)
(获取评级)
PetVivo Holdings, Inc, a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses.
PetVivo控股公司是一家生物医疗设备公司，从事治疗动物疾病和疾病的医疗设备和生物材料的制造、商业化和许可。它的主要产品是Spryng，一种由兽医管理的关节内注射，用于治疗跛行和其他关节疾病，如狗和马的骨关节炎。
Featured Articles
专题文章
- Get a free copy of the StockNews.com research report on PetVivo (PETV)
- Is This Medical Gear Maker Ready To Continue Its Rally?
- The Five (5) Hottest Stocks To Watch Ahead Of Q3 Earnings
- Has Take-Two Interactive Devolved into a One-Trick Pony?
- Is Lyft Going To Make It As Acquisition Rumors Swirl?
- Four Cheap Stocks With Interesting Insider Activity
- 免费获取StockNews.com关于PetVivo的研究报告(PETV)
- 这家医疗设备制造商准备好继续反弹了吗？
- 第三季度财报公布前最值得关注的五(5)只股票
- Take-Two Interactive是否已经退化为一招小马？
- 随着收购传言的甚嚣尘上，Lyft能否成功？
- 具有有趣内幕活动的四只廉价股票
Receive News & Ratings for PetVivo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetVivo and related companies with MarketBeat.com's FREE daily email newsletter.
接受PetVivo Daily的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对PetVivo和相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能，分享给你的好友吧